Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 2Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2CNS 2

Conditions

Glioblastoma 5Keratosis, Actinic 4Brain Neoplasms 4Glioma 3Astrocytoma 3Skin Neoplasms 2Gliosarcoma 2Skull Base Neoplasms 1Precancerous Conditions 1Oligodendroglioma 1Neoplasms 1Leukoplakia, Oral 1Head and Neck Neoplasms 1Carcinoma, Basal Cell 1Breast Neoplasms 1

Interventions

Temozolomide 19Radiotherapy 11Bevacizumab 7Radiation 4Irinotecan 4Erlotinib Hydrochloride 4carmustine, poliferprosan 20 drug combination 3Radiotherapy, Intensity-Modulated 3O(6)-benzylguanine 3Magnetic Resonance Spectroscopy 3Carmustine 32,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 3Vorinostat 2Surgical Procedures, Operative 2Radiotherapy, Conformal 2Radiosurgery 2Gadolinium DTPA 2Filgrastim 2Drug Therapy 2Congresses as Topic 2Cilengitide 2Chemotherapy, Adjuvant 2Aminolevulinic Acid 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2vitespin 1sargramostim 1sapanisertib 1poly ICLC 1plerixafor 1picropodophyllin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Gliosarcoma × Aminolevulinic Acid × Clear all
NCT01575275 2018-07-31

Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme

Case Comprehensive Cancer Center

Phase 2 Terminated
8 enrolled 7 charts
CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT01148966 2017-02-15

Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors

University of Washington

Phase 1 Terminated
6 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡